Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in Systemic Lupus Erythematosus (BLAST)
NCT02270970Phase 4Unknown
- Sponsor
- Oklahoma Medical Research Foundation
- Start
- Oct 2014
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 4 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by Oklahoma Medical Research Foundation. Status: unknown.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02270970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270970.